Does Biotech Reflect a New Science-based Innovation Regime?

95 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

From the gene to the globe: Extracting rents based on intellectual property monopolies (2007, background): “These institutional complementarities (Coriat et al., 2003: 240) together with the ascent of concentrated financial capital (investment, mutual and venture capital funds) have led to a finance-dominated biotechnology innovation system and the corresponding regime of intellectual property monopolies…”
Reconsidering the Bayh-Dole Act and the Current University Invention Ownership Model (2009, background): “…the transfer and commercialization process in the IT and engineering fields, then possibly TLOs and patents are more valuable in fields such as the biological sciences – an observation that academic research supports (Cohen and Walsh 2002; Coriat et al. 2003; Lim 2004; Merges and Nelson 1990).”
Differences in technology transfer between science-based and development based industries: transfer mechanisms and barriers (2011, background): “This knowledge is based on a limited number of technological fields (Coriat and Weinstein, 2001; Coriat et al., 2003), which reflects the relatively stand-alone nature of the as indicated by its low level of differentiation (Marsili, 2001).”